This article is available in English only.

Distributor Obligations: Verifying Medical Devices Under MDR Article 14

14 August 2026 · 8 min read

In short

  • Distributors must act with due care and verify that devices meet MDR requirements before making them available on the market, as per Article 14(1) MDR.
  • Key verifications include ensuring the device bears the CE marking, is accompanied by an EU Declaration of Conformity, and has appropriate labelling and instructions for use in the required language, according to Article 14(2) MDR.
  • Distributors must also confirm the assignment of a Unique Device Identification (UDI) to the device and verify the presence of authorised representative details for imported devices, as specified in Article 14(2)(c) and Article 13(3) MDR respectively.
  • If a device is deemed non-conformant or presents a serious risk, distributors must not make it available and must inform relevant economic operators and competent authorities, as outlined in Article 14(3) MDR.
  • Distributors are responsible for maintaining proper storage and transport conditions set by the manufacturer and for promptly forwarding complaints and incident reports, consistent with Article 14(4) and Article 14(5) MDR.

Medical device distributors play a crucial role in the supply chain, connecting manufacturers with end-users. Their responsibilities are clearly defined under the Medical Device Regulation (EU) 2017/745 (MDR), particularly in Article 14. These obligations ensure that only compliant and safe devices reach patients and healthcare professionals within the European Union.

General Obligations of Distributors

Article 14(1) MDR stipulates that when placing a device on the market, distributors must act with due care. This means they must verify that the requirements of the MDR are met. Their activities must not adversely affect a device's compliance with the MDR.

Verification Before Making a Device Available

Before making a device available on the market, distributors must perform several critical checks. These are outlined in Article 14(2) MDR and are fundamental to maintaining supply chain integrity and patient safety.

CE Marking and EU Declaration of Conformity

Distributors must verify that the device bears the CE marking, as required by Article 20 MDR. They must also ensure that the EU Declaration of Conformity (DoC) has been drawn up for the device. The DoC is a legal statement by the manufacturer confirming that the device meets the applicable requirements of the MDR.

Labelling and Instructions for Use

It is an obligation for distributors to verify that the device is accompanied by the information to be supplied by the manufacturer in accordance with Article 7 MDR. This includes the label and the instructions for use (IFU) in an official language of the Member State where the device is made available. The language requirement may be determined by national law, so distributors must check local regulations.

Unique Device Identification (UDI)

Distributors must confirm that the manufacturer has assigned a UDI to the device. Where applicable, this includes the UDI carrier on the device itself and on its packaging, as per Article 27 MDR.

Authorised Representative Details

For devices imported into the EU, distributors must ensure that the manufacturer has designated an authorised representative (AR), where required. The name, registered trade name or registered trade mark, and the address of the AR should be indicated on the device, its packaging, or in its IFU. This is specified in Article 13(3) MDR for importers, but distributors also have a role in verifying its presence.

Actions in Case of Non-Conformity

If a distributor considers or has reason to believe that a device is not in conformity with the requirements of the MDR, they must not make the device available on the market. This is a direct instruction from Article 14(3) MDR. Instead, they must inform the manufacturer, and the authorised representative if applicable, and the importer.

If the distributor considers or has reason to believe that the device presents a serious risk or is a falsified device, they must also inform the competent authority of the Member State where they are established. This obligation aligns with the broader market surveillance framework.

Storage and Transport Conditions

Article 14(4) MDR requires distributors to ensure that, while a device is under their responsibility, storage and transport conditions comply with the conditions set by the manufacturer. These conditions are typically specified in the device's labelling or instructions for use. Failure to adhere to these conditions can compromise device safety and performance.

Complaint Handling and Incident Reporting

Distributors are obliged to cooperate with the manufacturer and the authorised representative to ensure that the necessary corrective action is taken to bring the device into conformity, withdraw or recall it. This is detailed in Article 14(5) MDR.

Furthermore, if a distributor receives complaints or reports of suspected incidents in relation to a device they have made available, they must immediately forward this information to the manufacturer and the authorised representative. They must also keep a register of complaints and non-conforming devices, as specified in Article 14(6) MDR.

Distributors must also cooperate with competent authorities, providing them with all information and documentation necessary to demonstrate the conformity of the device, as outlined in Article 14(7) MDR. Upon request, they must provide free samples of the device or grant access to the device.

Traceability Obligations

For specific devices, as indicated by the Commission through implementing acts, distributors must be able to identify: the economic operator who supplied them with the device, and the economic operator to whom they have supplied a device. This traceability requirement is detailed in Article 25 MDR.

Example Traceability Record Keeping

Information to RecordSource of InformationRelevant MDR Article
Batch numberDevice Label/IFUArticle 25(1)
Serial numberDevice Label/IFUArticle 25(1)
UDIDevice Label/PackagingArticle 25(1)
Supplier name/addressInvoice/Delivery noteArticle 25(2)(a)
Customer name/addressInvoice/Delivery noteArticle 25(2)(b)
Date of transactionInvoice/Delivery noteArticle 25(2)

Common mistakes in practice

  • Failure to verify CE marking and DoC: Assuming compliance based solely on manufacturer claims, without physically checking for the CE mark and ensuring the EU Declaration of Conformity is available and valid. This contravenes Article 14(2)(a) MDR.
  • Incorrect language for IFU: Providing Instructions for Use only in English, even when the device is distributed in a Member State where other official languages are required by national law. This is a breach of Article 14(2)(b) MDR.
  • Neglecting storage conditions: Storing or transporting devices in conditions that deviate from those specified by the manufacturer, such as incorrect temperature or humidity, potentially compromising device integrity. This contradicts Article 14(4) MDR.
  • Not reporting issues: Failing to report suspected non-conformities, serious risks, or falsified devices to the manufacturer, AR, importer, or the national competent authority. This is a failure to comply with Article 14(3) MDR.
  • Inadequate traceability records: Not maintaining sufficient records to identify who supplied the device and to whom it was supplied, particularly for devices where specific traceability is mandated. This violates Article 25 MDR.
  • Ignoring complaints: Failing to forward complaints or suspected incident reports to the manufacturer or authorised representative promptly, as required by Article 14(5) MDR.

EUDAMED AI and Distributor Obligations

EUDAMED, the European database on medical devices, serves as a central repository for information related to medical devices. While distributors do not directly upload data to EUDAMED in the same way as manufacturers or authorised representatives, information from EUDAMED is crucial for their compliance. Distributors can utilise EUDAMED to verify device registrations, retrieve UDI data, and confirm the details of economic operators. EUDAMED AI can assist distributors by providing access to relevant data and facilitating the understanding of their compliance landscape. This platform helps navigate complex regulatory requirements and contributes to robust post-market surveillance. Learn more about its functionalities at https://eudamedai.com/#funkcije.

This material is for information only and is not legal advice. For binding interpretation consult your national competent authority.

Frequently asked questions

What are the main responsibilities of a medical device distributor under the MDR?
Under Article 14(1) MDR, distributors must act with due care to verify that devices comply with the MDR. This includes checking for CE marking, the EU Declaration of Conformity, appropriate labelling, instructions for use in the correct language, and UDI, as detailed in Article 14(2) MDR. They also have obligations regarding storage, incident reporting, and traceability.
What should a distributor do if they suspect a device is not compliant with the MDR?
If a distributor considers or has reason to believe a device is non-compliant, they must not make it available on the market. As per Article 14(3) MDR, they must inform the manufacturer, the authorised representative (if applicable), and the importer. If there is a serious risk or suspicion of a falsified device, the competent authority must also be informed.
Are distributors responsible for the storage conditions of medical devices?
Yes, Article 14(4) MDR states that distributors must ensure that, while a device is under their responsibility, its storage and transport conditions comply with those set by the manufacturer. Failure to do so can compromise device safety and efficacy.
Do distributors need to keep records of who supplied them with a device and to whom they supplied it?
Yes, for certain devices, distributors are required by Article 25 MDR to maintain records that identify both the economic operator who supplied them with the device and the economic operator to whom they have supplied a device. This ensures traceability throughout the supply chain.
How do distributors handle complaints or incidents related to devices?
According to Article 14(5) MDR, distributors must immediately forward any complaints or reports of suspected incidents in relation to a device they have made available to the manufacturer and the authorised representative. They must also keep a register of such complaints and non-conforming devices.

Sources

  1. Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devicesOfficial Journal of the European Union, EUR-Lex
  2. MDCG 2021-27, Questions and Answers on Articles 13 & 14 of Regulation (EU) 2017/745 and Regulation (EU) 2017/746Medical Device Coordination Group (MDCG)
  3. MDCG 2021-25, Guidance on the communication between authorised representatives, importers, distributors and manufacturersMedical Device Coordination Group (MDCG)

AuthorUredništvo EUdaMed AI

Related articles

Take control of your compliance data

Device register, sampling plan, reviews and inspection-ready exports in one place.

Join the waitlist